comprehensive -WSS

comprehensive

author：knowledge 2025-08-23 08:52:38 - browse：2991

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Fentanyl is making it harder to start addiction treatment

WSS

Medtronic CEO on promising devices for diabetes, hypertension

FDA has safety concerns on CRISPR

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Medtronic CEO on promising devices for diabetes, hypertension

Medtronic CEO on promising devices for diabetes, hypertension

Fentanyl is making it harder to start addiction treatment

entertainment

comprehensive

explore

Medical leaders decry Supreme Court decision on affirmative action

As a primary care physician, here's how I hope to partner with AI

How one medical school became remarkably diverse

Listen: A conversation with researcher Kevin Esvelt on biosecurity

What does generative AI mean for health care? We asked experts

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Jerome Adams on the need for new antivirals for Covid

The FDA weighs the risks of candy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly to pay $200M for Beam’s stake in gene

leisure time

Hospitals warn Medicare's drug payment fix is ‘unlawful’

The pink breast cancer awareness ribbon needs a redesign

Readout Newsletter: XBI biotech index, Akero Therapeutics

ASCO eve: Let’s set the table for this year's meeting

Why Sanofi got shellacked over its spinoff

Investigation reveals sickle cell patients pressured into sterilizations

leisure time

hotspot

knowledge

focus